StockData
Impact BioMedical Inc. logo

Impact BioMedical Inc. (IBO) stock

IBONYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$3.06+0.38 (+14.18%)

Close on Oct 19, 2026Market cap $329.93MP/E –Yield –

Impact BioMedical enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Impact BioMedical's enterprise value was $29.28M on Oct 19, 2026, against $2.85M a year earlier. Over the last 2 years it ranged from $1.37M to $50.90M, with a median of $4.78M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$29.28M+753.8%
2025Dec 31, 2025$3.43M-64.4%
2024Dec 31, 2024$9.62M–

More Impact BioMedical figures

See a number that looks wrong?